Not logged in Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy Li, Howard L.; Charmsaz, Soren; Nakazawa, Mari; Alden, Stephanie L.; Brancati, Madelena; Leatherman, James M.; Griffin, Ervin; Tsai, Hua-Ling; Gross, Nicole E.; Thoburn, Christopher J.; Hernandez, Alexei; Coyne, Erin M.; Shin, Sarah M.; Lee, Royce P.; Lipson, Evan J.; Johnson III, Burles A.; Pabani, Aliyah; Ged, Yasser; Baretti, Marina; Brahmer, Julie R.; Hoffman-Censits, Jean; Seiwert, Tanguy Y.; Zabransky, Daniel J.; Durham, Jennifer N.; Jaffee, Elizabeth M.; Chandler, G. Scott; Adler, Brittany L.; Ho, Won Jin; Kao, Chester; Yarchoan, Mark Share Save
Share Save
Higher levels of VEGF-A and TNFα in patients with immune checkpoint inhibitor-induced inflammatory arthritis Gray-Gaillard, Elise F.; Shah, Ami A.; Bingham III, Clifton O.; Elisseeff, Jennifer H.; Murray, Joseph; Brahmer, Julie; Forde, Patrick; Anagnostou, Valsamo; Mammen, Jennifer; Cappelli, Laura C. Share Save
Lung cancer research and treatment: global perspectives and strategic calls to action Meyer, M. -l.; Peters, S.; Mok, T. S.; Lam, S.; Yang, P. -c.; Aggarwal, C.; Brahmer, J.; Dziadziuszko, R.; Felip, E.; Ferris, A.; Forde, P. M.; Gray, J.; Gros, L.; Halmos, B.; Herbst, R.; Jaenne, P. A.; Johnson, B. E.; Kelly, K.; Leighl, N. B.; Liu, S.; Lowy, I.; Marron, T. U.; Paz-Ares, L.; Rizvi, N.; Rudin, C. M.; Shum, E.; Stahel, R.; Trunova, N.; Bunn, P. A.; Hirsch, F. R. Share Save
Management of Immunotherapy-Related Toxicities, Version 2.2024 Featured Updates to the NCCN Guidelines Thompson, John A.; Schneider, Bryan J.; Brahmer, Julie; Abu Zaid, Mohammad; Achufusi, Amaka; Armand, Philippe; Berkenstock, Meghan K.; Bermas, Bonnie; Braaten, Tawnie; Budde, Lihua E.; Chokshi, Saurin; Crees, Zachary D.; Davies, Marianne; Deng, Changchun; Gesthalter, Yaron; Jain, Michael; Jain, Prantesh; Jallouk, Andrew; Kaffenberger, Benjamin H.; Khalil, Maya; Lechner, Melissa G.; Li, Tianhong; Marr, Alissa; Mcgettigan, Suzanne; Mcpherson, Jordan; Medina, Theresa; Mohindra, Nisha A.; Olszanski, Anthony J.; Oluwole, Olalekan; Patel, Sandip P.; Prosek, Jason; Reddy, Sunil; Reid, Pankti; Ryan, John; Ryder, Mabel; Salman, Huda; Santomasso, Bianca; Shofer, Scott; Sosman, Jeffrey A.; Wang, Yinghong; Zaha, Vlad G.; Zucker, Stephen; Lyons, Megan; Awotiwon, Ajibola; Hang, Lisa Share Save
Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures Kao, Chester J.; Charmsaz, Soren; Alden, Stephanie L.; Brancati, Madelena; Li, Howard L.; Balaji, Aanika; Munjal, Kabeer; Howe, Kathryn; Mitchell, Sarah; Leatherman, James; Griffin, Ervin; Nakazawa, Mari; Tsai, Hua-Ling; Danilova, Ludmila; Thoburn, Chris; Gizzi, Jennifer; Gross, Nicole E.; Hernandez, Alexei; Coyne, Erin M.; Shin, Sarah M.; Babu, Jayalaxmi Suresh; Apostol, George W.; Durham, Jennifer; Christmas, Brian J.; Konig, Maximilian F.; Lipson, Evan J.; Naidoo, Jarushka; Cappelli, Laura C.; Pabani, Aliyah; Ged, Yasser; Baretti, Marina; Brahmer, Julie; Hoffman-Censits, Jean; Seiwert, Tanguy Y.; Garonce-Hediger, Rachel; Guha, Aditi; Bansal, Sanjay; Tang, Laura; Jaffee, Elizabeth M.; Chandler, G. Scott; Mohindra, Rajat; Ho, Won Jin; Yarchoan, Mark Share Save
Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer (vol 24, pg 638, 2018) Robichaux, Jacqulyne P.; Elamin, Yasir Y.; Tan, Zhi; Carter, Brett W.; Zhang, Shuxing; Liu, Shengwu; Li, Shuai; Chen, Ting; Poteete, Alissa; Estrada-Bernal, Adriana; Le, Anh T.; Truini, Anna; Nilsson, Monique B.; Sun, Huiying; Roarty, Emily; Goldberg, Sarah B.; Brahmer, Julie R.; Altan, Mehmet; Lu, Charles; Papadimitrakopoulou, Vassiliki; Politi, Katerina; Doebele, Robert C.; Wong, Kwok-Kin; Heymach, John V. Share Save
First-line Osimertinib for Lung Cancer With Uncommon EGFR Exon 19 Mutations and EGFR Compound Mutations Cheunkarndee, Tia; Guo, Matthew Z.; Houseknecht, Stefanie; Feliciano, Josephine L.; Hann, Christine L.; Lam, Vincent K.; Levy, Benjamin P.; Murray, Joseph C.; Brahmer, Julie R.; Forde, Patrick M.; Marrone, Kristen A.; Scott, Susan C. Share Save
Phase 2 study of oral CCR4 antagonist FLX475 (tivumecirnon) plus pembrolizumab in subjects with head and neck squamous cell carcinoma (HNSCC) previously treated with checkpoint inhibitor Muzaffar, Jameel; Kirtane, Kedar; Redman, Rebecca; Yang, Muh-Hwa; Kim, Tae Min; Liu, Stephen; Lynch, Ryan; Brahmer, Julie; LoRusso, Patricia; Henick, Brian; Kim, Sung-Bae; Feng, Yin-Hsun; Chisamore, Michael; Kassner, Paul; Brockstedt, Dirk; Nasrah, Nicole; Goyal, Rakesh; Ho, William Y.; Villaflor, Victoria Share Save
The obesity paradox in immune checkpoint blockade: A pan-tumor analysis Alden, Stephanie Leigh; Charmsaz, Soren; Brancati, Madelena; Li, Howard L.; Warner, Aanika; Munjal, Kabeer; Howe, Kathryn; Mitchell, Sarah; Griffin, Ervin; Nakazawa, Mari; Tsai, Hua-Ling; Danilova, Ludmila; Thoburn, Chris; Gizzi, Jennifer; Hernandez, Alexei; Gross, Nicole E.; Coyne, Erin M.; Shin, Sarah M.; Durham, Jennifer; Konig, Maximilian F.; Christmas, Brian J.; Lipson, Evan J.; Naidoo, Jarushka; Cappelli, Laura C.; Pabani, Aliyah; Ged, Yasser; Baretti, Marina; Brahmer, Julie R.; Hoffman-Censits, Jean; Seiwert, Tanguy Y.; Bansal, Sanjay; Tang, Laura; Jaffee, Elizabeth; Chandler, G. Scott; Mohindra, Rajat; Ho, Won Jin; Yarchoan, Mark; Kao, Chester Share Save
Liquid biopsy-informed precision oncology clinical trial to evaluate the utility of ctDNA comprehensive genomic profiling Fatteh, Maria; Conroy, Michael; Wanchoo, Timsy; Teh, Selina Shiqing; Wehr, Jaime; Balan, Archana; Karchin, Rachel; Verner, Ellen; Karaindrou, Katerina; Xian, Rena; Gocke, Christopher; Lin, Ming-Tseh; Fitzpatrick, Peggy; Hann, Christine L.; Murray, Joseph C.; Lam, Vincent K.; Feliciano, Josephine L.; Brahmer, Julie R.; Marrone, Kristen A.; Forde, Patrick M.; Fiallos, Katie; Petry, Dana; Botsis, Taxiarchis; Sausen, Mark; Canzoniero, Jenna; Tao, Jessica; Anagnostou, Valsamo Share Save
Comprehensive genomic and transcriptomic analyses capture the effects of epigenetic therapy priming on immune checkpoint blockade response in non-small cell lung cancer Landon, Blair V.; Marrone, Kristen A.; Topper, Michael J.; Annapragada, Akshaya; Tsai, Hua-Ling; Balan, Archana; Niknafs, Noushin; Cherry, Christopher; White, James R.; Pereira, Gavin; Adleff, Vilmos; Hu, Chen; Riemer, Joanne; Fitzpatrick, Margaret; Forde, Patrick; Hann, Christine L.; Kelly, Ronan J.; Ettinger, David S.; Levy, Benjamin; Nieva, Jorge; Herman, James; Velculescu, Victor E.; Baylin, Stephen; Brahmer, Julie; Anagnostou, Valsamo Share Save
Clinical and Genomic Characterization of Long-Term Responders Receiving Immune Checkpoint Blockade for Metastatic Non-Small-Cell Lung Cancer Ghanem, Paola; Murray, Joseph C.; Hsu, Melinda; Guo, Matthew Z.; Ettinger, David S.; Feliciano, Josephine; Forde, Patrick; Hann, Christine L.; Lam, Vincent K.; Levy, Benjamin; Anagnostou, Valsamo; Brahmer, Julie R.; Marrone, Kristen A. Share Save
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients Brahmer, Julie R.; Long, Georgina, V; Hamid, Omid; Garon, Edward B.; Herbst, Roy S.; Andre, Thierry; Armand, Philippe; Bajorin, Dean; Bellmunt, Joaquim; Burtness, Barbara; Choueiri, Toni K.; Cohen, Ezra E. W.; Diaz Jr, Luis A.; Shitara, Kohei; Kulkarni, Girish; McDermott, David; Shah, Manish; Tabernero, Josep; Vogel, Arndt; Zinzani, Pier Luigi; Jafari, Niusha; Birdu, Steven; Snyderu, Ellen; Gause, Christine; Braccou, Oswaldo L.; Pietanza, M. Catherine; Gruberu, Todd; Ribas, Antoni Share Save
Clinical features and outcomes of advanced HER2D esophageal/GEJ cancer with brain metastasis Liang, K.; Feliciano, J. L.; Marrone, K. A.; Murray, J. C.; Hann, C. L.; Anagnostou, V.; Tackett, S. A.; Shin, E. J.; Hales, R. K.; Voong, K. R.; Battafarano, R. J.; Yang, S. C.; Broderick, S. R.; Ha, J. S.; Forde, P. M.; Brahmer, J. R.; Lam, V. K. Share Save
Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: results of the phase III CheckMate 227 Part 2 trial Borghaeit, H.; O'Byrnet, K. J.; Paz-Ares, L.; Ciuleanu, T. -E; Yu, X.; Pluzanski, A.; Nagrial, A.; Havel, L.; Kowalyszyn, R. D.; Valette, C. A.; Brahmer, J. R.; Reck, M.; Ramalingam, S. S.; Zhang, L.; Ntambwe, I.; Rabindran, S. K.; Nathan, F. E.; Balli, D.; Wu, Y. -L. Share Save
ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results Anagnostou, Valsamo; Ho, Cheryl; Nicholas, Garth; Juergens, Rosalyn Anne; Sacher, Adrian; Fung, Andrea S.; Wheatley-Price, Paul; Laurie, Scott A.; Levy, Benjamin; Brahmer, Julie R.; Balan, Archana; Niknafs, Noushin; Avrutin, Egor; Zhu, Liting; Sausen, Mark; Bradbury, Penelope A.; O'Donnell-Tormey, Jill; Gaudreau, Pierre Olivier; Ding, Keyue; Dancey, Janet Share Save
Phase Ib multicenter study of trastuzumab deruxtecan (T-DXd) and immunotherapy with or without chemotherapy in first-line treatment of patients (pts) with advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) and HER2 overexpression (OE): DESTINY-Lung03 Planchard, D.; Brahmer, J. R.; Yang, J. C-H.; Kim, H. R.; Li, R. K.; Han, J-Y.; Cortinovis, D. L.; Runglodvatana, Y.; Nakajima, E.; Ragone, A.; Winter, M.; Gustavson, M. Share Save
Neoadjuvant nivolumab (N) plus chemotherapy (C) in the phase III CheckMate 816 study: 3-y results by tumor PD-L1 expression Pulla, M. Provencio; Forde, P. M.; Spicer, J. D.; Wang, C.; Lu, S.; Mitsudomi, T.; Awad, M. M.; Felip, E.; Broderick, S.; Swanson, S. J.; Brahmer, J. R.; Kerr, K. M.; Saylors, G.; Tanaka, F.; Chen, K. N.; Tran, M. P.; Cai, J. L.; Mahmood, J.; Meadows-Shropshire, S.; Girard, N. Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF ONCOLOGY.png)
OAAI
.png){kind=icon}
Share.png){kind=icon}
Save